French drug company Sanofi and Alphabet Inc.'s Verily Life Sciences LLC have teamed up to form a new joint venture dubbed Onduo, which will look to aid individuals suffering from diabetes.
Business Tech September 12, 2016
The dengue vaccine currently used in about six countries could make people sick rather than protect them if not used appropriately. Researchers advise that the vaccine should be used depending on the infection rate of the locality.
Public Health September 3, 2016
Sanofi Pasteur said it has launched a vaccine research and development project for Zika virus. This is considered the first considerable commitment from a major vaccine firm to fight the disease already declared an international emergency by WHO.
Life February 2, 2016
Basaglar diabetes drug is a long-acting, man-made human insulin therapy recently approved by the FDA. It is made by Eli Lilly in partnership with Boehringer Ingelheim as a cheaper version of Sanofi's Lantus drug.
Life December 17, 2015
French drug maker Sanofi-Aventis recalls Auvi-Q and Allerject in U.S. and Canada for alleged inaccurate doses. The two products are staples in anaphylaxis first aid, wherein an incorrect dosage could be fatal.
Life October 30, 2015
Express Scripts announced that they will be paying for Amgen and Regeneron/Sanofi's costly cholesterol drugs for their members. The company said they were able to negotiate the best prices and thus is now confident in providing the medicines under certain conditions.
Life October 8, 2015
Praluent is now going to be made available in Europe as the European Commission signs off on the anti-cholesterol drug from Regeneron and Sanofi.
Life September 28, 2015
Google is partnering up with French pharmaceutical company Sanofi, the maker of the world’s best-selling insulin, to improve the management and treatment of diabetes.
Deals August 31, 2015
French drug company Sanofi reports that it is teaming up with biotech companies Evotec of Germany and Apeiron Biologics of Austria to develop new small molecule-based immuno-oncology treatments to treat solid and hematological cancers.
Life August 10, 2015
By summer, Americans could be enjoying two new drugs in different doses designed to effectively lower levels of bad cholesterol in the body and improve health management.
Life May 27, 2015
Sanofi's inhalable insulin Afrezza not available in the U.S. market. Afrezza may give competition to rivals making traditional injectable insulin but Afrezza has a steep price tag.
Life February 3, 2015
French drugmaker Sanofi announces that it will bring the world's first dengue vaccine by the second half of 2015. Clinical trials of the vaccine have already been completed and the vaccine is also under production.
Life November 6, 2014
Dealing with heart health is a balancing act. Is this experimental drug from Sanofi and Regeneron, what millions of cardiovascular disease patients, have been waiting for?
Life September 1, 2014
The FDA has asked that Sanofi and Regeneron test a new cholesterol-fighting drug, alirocumab, for the possibility of neurocognitive inference or damage.
Life March 7, 2014